PSMD1 and COVID-19: To test whether COVID-19 might lead to metabolic changes that persist even after asymptomatic infection or mild disease, we analyzed serum samples from 18 anti-S1-IgG+ and compared them with age- and sex-matched controls anti-S1-IgG-.